
|Videos|November 11, 2015
Q&A With Matthew G. Nayor From Brigham & Women's Hospital: Framingham Heart Study Looks At Impact of Carbon Monoxide
Author(s)Adam Hochron
The Framingham Heart Study has been one of the most in depth studies in the field of cardiology and medicine as a whole. A recent portion of the study looked at the impact of carbon monoxide exhalation and its role in patient health.
Advertisement
The Framingham Heart Study has been one of the most in depth studies in the field of cardiology and medicine as a whole. A recent portion of the study looked at the impact of carbon monoxide exhalation and its role in patient health.
Matthew Nayor, MD, from Brigham & Women's Hospital discussed the results of this study during the annual scientific sessions of the American Heart Association in Orlando.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
5


























































